DarDoc Research

GLP-1 Trial & Approval Tracker

Compare GLP-1 trial arms

Compare results within a trial or inspect the context behind results from different studies.

SURMOUNT-2

Mounjaro

With type 2 diabetes · 72 weeks · n=938

Double-blind, placebo-controlled. Treatment-regimen analysis.

Mean body weight change at 72 weeks
  • Tirzepatide 10 mg−12.8%
  • Tirzepatide 15 mg−14.7%
  • Placebo−3.2%
Published paper PubMed abstract NCT04657003

A direct comparison uses arms from the same trial. Switch to Two studies to inspect the context behind separate results.